Aleksandra Zuraw
Overview
Explore the profile of Aleksandra Zuraw including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
118
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zuraw A, Aeffner F
Vet Pathol
. 2021 Sep;
59(1):6-25.
PMID: 34521285
Since whole-slide imaging has been commercially available for over 2 decades, digital pathology has become a constantly expanding aspect of the pathology profession that will continue to significantly impact how...
2.
Wharton Jr K, Wood D, Manesse M, Maclean K, Leiss F, Zuraw A
Front Mol Biosci
. 2021 Aug;
8:672531.
PMID: 34386519
Multiplex tissue analysis has revolutionized our understanding of the tumor microenvironment (TME) with implications for biomarker development and diagnostic testing. Multiplex labeling is used for specific clinical situations, but there...
3.
Kapil A, Meier A, Steele K, Rebelatto M, Nekolla K, Haragan A, et al.
IEEE Trans Med Imaging
. 2021 May;
40(9):2513-2523.
PMID: 34003747
We report the ability of two deep learning-based decision systems to stratify non-small cell lung cancer (NSCLC) patients treated with checkpoint inhibitor therapy into two distinct survival groups. Both systems...
4.
Turner O, Knight B, Zuraw A, Litjens G, Rudmann D
Toxicol Pathol
. 2021 Feb;
49(4):714-719.
PMID: 33590805
The 2019 manuscript by the Special Interest Group on Digital Pathology and Image Analysis of the Society of Toxicologic pathology suggested that a synergism between artificial intelligence (AI) and machine...
5.
Bedard A, Westerling-Bui T, Zuraw A
Toxicol Pathol
. 2021 Feb;
49(4):897-904.
PMID: 33576323
Inflammatory bowel disease (IBD) is a complex disease which leads to life-threatening complications and decreased quality of life. The dextran sulfate sodium (DSS) colitis model in mice is known for...
6.
Zuraw A, Staup M, Klopfleisch R, Aeffner F, Brown D, Westerling-Bui T, et al.
Toxicol Pathol
. 2020 Dec;
49(4):773-783.
PMID: 33371797
Digital tissue image analysis is a computational method for analyzing whole-slide images and extracting large, complex, and quantitative data sets. However, as with any analysis method, the quality of generated...
7.
Buchanich J, Grigson P, Deneke E, Vrana K, Sacks D, Kuehn G, et al.
Ann Clin Lab Sci
. 2019 Jul;
49(3):403-416.
PMID: 31308044
No abstract available.
8.
Zuraw A, Plog S, Lierz M, Gruber A
Vet Parasitol Reg Stud Reports
. 2019 Apr;
3-4:49-52.
PMID: 31014499
Sarcocystis calchasi has recently been identified as the cause of pigeon protozoal encephalitis, PPE, a lethal brain disease in pigeons and parrots. While only avian species have been identified so...
9.
Bochnia M, Sander J, Ziegler J, Terhardt M, Sander S, Janzen N, et al.
PLoS One
. 2019 Feb;
14(2):e0211698.
PMID: 30721263
Atypical myopathy (AM) in horses is caused by ingestion of seeds of the Acer species (Sapindaceae family). Methylenecyclopropylacetyl-CoA (MCPA-CoA), derived from hypoglycin A (HGA), is currently the only active toxin...
10.
Kapil A, Meier A, Zuraw A, Steele K, Rebelatto M, Schmidt G, et al.
Sci Rep
. 2018 Nov;
8(1):17343.
PMID: 30478349
The level of PD-L1 expression in immunohistochemistry (IHC) assays is a key biomarker for the identification of Non-Small-Cell-Lung-Cancer (NSCLC) patients that may respond to anti PD-1/PD-L1 treatments. The quantification of...